Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,241 | 2,288 | 17,724 | 17,356 | 1,579 |
| TOTAL | $2,735 | $3,582 | $18,432 | $17,737 | $2,279 |
| Non-Current Assets | |||||
| PPE Net | 306 | 507 | 678 | 294 | N/A |
| Intangibles | 42 | 211 | 380 | 8,512 | 1,818 |
| Other Non-Current Assets | 0 | 0 | 64 | 176 | 0 |
| TOTAL | $348 | $718 | $1,121 | $8,982 | $1,818 |
| Total Assets | $3,083 | $4,300 | $19,553 | $26,719 | $4,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 755 | 1,219 | 463 | 683 | 681 |
| Other current liabilities | 3 | 49 | 1,763 | 1,946 | N/A |
| TOTAL | $1,490 | $2,344 | $3,996 | $2,737 | $681 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 885 | 69 | 0 |
| TOTAL | $N/A | $N/A | $885 | $1,676 | $N/A |
| Total Liabilities | $1,490 | $2,344 | $4,881 | $4,413 | $681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 206 | 41 | 12 | 6 | 2 |
| Common Shares | 7 | 2 | 21 | 7 | 101 |
| Retained earnings | -106,075 | -96,500 | -79,208 | -60,737 | -11,760 |
| Other shareholders' equity | -595 | -2,387 | -537 | -31 | -181 |
| TOTAL | $1,593 | $1,956 | $14,672 | $22,306 | $3,416 |
| Total Liabilities And Equity | $3,083 | $4,300 | $19,553 | $26,719 | $4,097 |